Type 2 diabetes has traditionally been considered a non-reversible chronic disease. However, accumulated evidence suggests that among those in early-stage disease who are not receiving insulin treatment, remission can be achieved through substantial weight loss using low-energy and very-low-energy total diet replacement (LED and VLED TDR) interventions (1). The effectiveness of LED and VLED interventions on rapid weight loss and remission outcomes has been consistently demonstrated in existing studies across multiple countries (2-4). The DIRECT-Aus LED trial replicated the findings of the landmark DIRECT UK trial, achieving diabetes remission in 56% of participants at one year (2, 4). This indicates the strong potential for these intensive lifestyle interventions to shift the focus diabetes care from medication-centred glycaemic management towards remission. However, currently there is limited understanding of consumers’ experiences and acceptability of these interventions. This scoping review aimed to map the existing literature and provide an overview of the insights and experiences of consumers undertaking LED and VLED formula diet interventions for type 2 diabetes management. A comprehensive literature search was conducted across five selected medical and health databases (from inception to February 2026) following the PRISMA Extension for Scoping Reviews and the Joanna Briggs Institute methodological guidelines. A total of 2699 records were identified. Fifteen studies met the eligibility criteria and were included for data extraction. All included studies were conducted in high-income Western countries, with the duration of intensive TDR phase ranging between eight and 12 weeks. Overall, LED and VLED interventions were acceptable to participants, and TDR products (that is, nutritionally completed shakes) were reported to be well tolerated. Key motivations for participation and continued involvement in the initial intensive TDR phase included the anticipated potential for T2DM remission and rapid weight loss. Broader benefits such as improvements in physical and psychosocial wellbeing were recognised in later stages during the food reintroduction and weight maintenance phases of the program. Mild side effects were observed but typically diminished after adaptation. Regarding perceived barriers, consumers expressed a desire for more timely and continuous support from the research team as challenges emerged throughout the intervention. Other challenges included inconsistencies in communication and education delivery, limited psychological support, and lack of considerations on cultural variety and practical food modification strategies. These promising findings demonstrate the role of meal replacement-based interventions as an acceptable component within type 2 diabetes remission programs, although several areas for improvement warrant further attention. Future intervention should incorporate more practical, tailored, and culturally appropriate support to optimise consumer engagement and intervention outcomes. There is also a strong need to move beyond short-term outcomes, focusing on better understanding of how intervention-induced outcomes can be translated into sustainable healthy eating behaviours and better overall wellbeing in everyday life.